Psma Pet Ct Positive Advanced Metastatic Tumours clinical trials

Explore recruiting psma pet ct positive advanced metastatic tumours clinical trials.

Also recruiting in Europe

Psma Pet Ct Positive Advanced Metastatic Tumours trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Radiometabolic Therapy (RMT) with 177Lu PSMA in PSMA PET/CT positive advanced/metastatic tumours: a basket trial (LUBASKET)

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Psma Pet Ct Positive Advanced Metastatic Tumours trials by city

Psma Pet Ct Positive Advanced Metastatic Tumours in Toronto Psma Pet Ct Positive Advanced Metastatic Tumours in Vancouver Psma Pet Ct Positive Advanced Metastatic Tumours in Montreal Psma Pet Ct Positive Advanced Metastatic Tumours in Calgary Psma Pet Ct Positive Advanced Metastatic Tumours in Edmonton Psma Pet Ct Positive Advanced Metastatic Tumours in Ottawa Psma Pet Ct Positive Advanced Metastatic Tumours in Winnipeg Psma Pet Ct Positive Advanced Metastatic Tumours in Quebec City Psma Pet Ct Positive Advanced Metastatic Tumours in Hamilton Psma Pet Ct Positive Advanced Metastatic Tumours in Kitchener Psma Pet Ct Positive Advanced Metastatic Tumours in London Psma Pet Ct Positive Advanced Metastatic Tumours in Halifax Psma Pet Ct Positive Advanced Metastatic Tumours in New York Psma Pet Ct Positive Advanced Metastatic Tumours in Los Angeles Psma Pet Ct Positive Advanced Metastatic Tumours in Chicago Psma Pet Ct Positive Advanced Metastatic Tumours in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease